X4 Pharmaceuticals (XFOR) Change in Receivables (2020 - 2025)
X4 Pharmaceuticals (XFOR) posted Change in Receivables of -$318000.0 for Q4 2025, down 25.2% on a QoQ basis from -$254000.0 in Q3 2025, and down 129.72% year-over-year from $1.1 million in Q4 2024.
X4 Pharmaceuticals (XFOR) Change in Receivables (2020 - 2025) Analysis & Trends
X4 Pharmaceuticals' Change in Receivables history runs 3 years deep, the most recent figure standing at -$318000.0 for Q4 2025.
- Quarterly Change in Receivables fell 129.72% year-over-year to -$318000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$497000.0 (down 146.45% YoY) and the FY2025 annual result came in at -$497000.0, down 146.45% from the prior year.
- Change in Receivables was -$318000.0 for Q4 2025 at X4 Pharmaceuticals, down from -$254000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $1.1 million in Q4 2024 and bottomed at -$561000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | X4 Pharmaceuticals | 167.90 Mn | -49.15 Mn | 2.20 Mn | -318,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -318,000.00 |
| Dec 31, 2025 | -318,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Jun 30, 2025 | 636,000.00 |
| Jun 30, 2025 | 636,000.00 |
| Mar 31, 2025 | -561,000.00 |
| Mar 31, 2025 | -561,000.00 |
| Dec 31, 2024 | 1.07 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Mar 31, 2020 | 3.00 Mn |
| Mar 31, 2020 | 3.00 Mn |